#  Rhea Sahu 

Biological and Biomedical Sciences, Karen Cichowski Lab

 

 

 



   ![Rhea Sahu](/sites/g/files/omnuum5431/files/styles/hwp_4_5__480x600/public/landrycancerbio/files/sahu_rhea.jpg?itok=uKHLQtnv) 

 



 





 

Rhea grew up in India and Switzerland, and graduated with honors from University of California, Los Angeles (UCLA) with a Bachelor of Science in Molecular, Cell and Developmental Biology and a minor in Biomedical Research. She began her research career at UCLA in Steve Jacobsen’s Lab studying DNAJ1, a novel activator protein involved in non-canonical methylation-dependent gene expression. Over time, her research interests evolved and she specifically became attracted to investigating epigenetic and signaling mechanisms that drive cancer, leading to discovery of therapeutic vulnerabilities. She is now a PhD candidate in the Biological and Biomedical Sciences (BBS) program at Harvard, and her research involves co-targeting oncogenic and epigenetic pathways in castration-resistant prostate cancer in Karen Cichowski’s Lab.